Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer
Journal article published in 2018 by
S. M. de Boer,
B. G. Wortman 
,
T. Bosse,
M. E. Powell,
N. Singh,
H. Hollema,
G. Wilson,
M. N. Chowdhury,
L. Mileshkin,
J. Pyman,
D. Katsaros,
S. Carinelli,
A. Fyles,
C. M. McLachlin,
C. Haie-Meder
and other authors.
,
T. Bosse,
M. E. Powell,
N. Singh,
H. Hollema,
G. Wilson,
M. N. Chowdhury,
L. Mileshkin,
J. Pyman,
D. Katsaros,
S. Carinelli,
A. Fyles,
C. M. McLachlin,
C. Haie-Meder
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 